Trial
NCT03938272
An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
OxThera
Collaborators
—
Condition
Hyperoxaluria, Primary
Intervention
Oxabact OC5 - Oxalobacter formigenes Strain HC-1
Why stopped
Parent, pivotal study (OC5-DB-02) did not meet primary endpoint. No safety concerns for early termination.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-08